Trends in prescription drug expenditures by Medicaid enrollees

Medical Care
Jessica S Banthin, G Edward Miller

Abstract

As prescription drug expenditures consume an increasingly larger portion of Medicaid budgets, states are anxious to control drug costs without endangering enrollees' health. In this report, we analyzed recent trends in Medicaid prescription drug expenditures by therapeutic classes and subclasses. Identifying the fastest growing categories of drugs, where drugs are grouped into clinically relevant classes and subclasses, can help policymakers decide where to focus their cost containment efforts. We used data from the Medical Expenditure Panel Survey linked to a prescription drug therapeutic classification system, to examine trends between 1996/1997 and 2001/2002 in utilization and expenditures for the noninstitutionalized Medicaid population. We separated aggregate trends into changes in population with use and changes in expenditures per user, and percent generic. We also highlighted differences within the Medicaid population, including children, adults, disabled, and elderly. We found rapid growth in expenditures for antidepressants, antipsychotics, antihyperlipidemics, antidiabetic agents, antihistamines, COX-2 inhibitors, and proton pump inhibitors and found evidence supporting the rapid take-up of new drugs. In some cases t...Continue Reading

References

Jan 13, 2000·Journal of General Internal Medicine·S R MajumdarS B Soumerai
May 2, 2001·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·J Moeller
Aug 2, 2003·Health Affairs·UNKNOWN Reforming States Group
Mar 9, 2004·Health Affairs·Katharine LevitUNKNOWN Health Accounts Team
Mar 30, 2006·Inquiry : a Journal of Medical Care Organization, Provision and Financing·G Edward MillerRandall S Stafford

❮ Previous
Next ❯

Citations

Dec 27, 2011·Journal of Clinical Psychopharmacology·Jennifer M PolinskiSebastian Schneeweiss
Apr 26, 2007·PLoS Medicine·Adriane Fugh-Berman, Shahram Ahari
Feb 5, 2009·The Journal of Clinical Psychiatry·Daniel M HartungBentson H McFarland
Nov 15, 2014·Health Services & Outcomes Research Methodology·Marisa Elena Domino, Christopher Alan Beadles
Mar 14, 2007·Journal of Nursing Care Quality·Ronda G Hughes, Carolyn M Clancy
Jun 24, 2011·Journal of Health Economics·Anirban BasuTomas J Philipson
Apr 28, 2009·Clinical Therapeutics·Jaana E Martikainen, Hannes Enlund
Sep 17, 2008·Research in Social & Administrative Pharmacy : RSAP·Junling WangShelley I White-Means
Sep 17, 2008·Research in Social & Administrative Pharmacy : RSAP·Yan ChenNick C Patel
Jan 31, 2013·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·R S ChoungN J Talley
Mar 19, 2014·Health Services Research·Marcela Horvitz-LennonSharon-Lise T Normand
Jan 8, 2011·The International Journal of Neuropsychopharmacology·Juliana Sartori BoniniMartín Cammarota
Aug 14, 2010·Medical Care·Jaana E MartikainenArja Helin-Salmivaara
May 9, 2007·Health Affairs·Jennifer M PolinskiMichael A Fischer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

© 2022 Meta ULC. All rights reserved